Immunotherapies, anti-cancer treatments that enhance the immune system's ability to kill cancer cells, have made notable ...

An important advance in cancer therapeutics has been achieved by scientists at the Tianjin University School of Medicine, who have developed a new “microbial fuel cell” platform that integrates ...

Chinese Medical Journals Publishing House Co., Ltd. Breast cancer (BC) contributes greatly to global cancer incidence and is the main cause of cancer-related deaths among women globally. It is a ...

Targeted cancer drugs known as CDK4/6 inhibitors have improved outcomes for patients with advanced or metastatic HR+/HER2- breast cancer, but many patients still eventually relapse and become ...

The tumor microenvironment (TME) is one of the most formidable barriers to durable cancer immunotherapy. Far from being a passive bystander, the TME ...

Targeting the virus at entry To breach the immune system, EBV depends on two surface proteins: gp350 and gp42. It uses these ...

Before starting cell therapy, patients need more than hope — they need a plan. Dr. Muhammad Tariq breaks down what to expect ...

Adults with blood cancers who need a donor stem cell transplant now have a new defense against one of the procedure’s most ...